Thamer A Almangour

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 10

Top Topics

Emergency Department

Respiratory Tract

Top Venues

International journal of environmental research and public health

Antibiotics (Basel, Switzerland)

Healthcare (Basel, Switzerland)

Antimicrobial agents and chemotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Thamer A Almangour, Hussain A Alali, Zakiyah Alkherb, Shuroug A Alowais, Khalid Bin Saleh, Sara Almuhisen, Abdullah Almohaizeie, Renad Alsahli, Shatha Alruwaite, Fai Alnashmi, Lolwa Fetyani, Noran Ibrahim Abouobaid, Alnajla Alghofaily, Khalifa M Binkhamis, Yazed Saleh Alsowaida
Monotherapy versus combination for the treatment of Stenotrophomonas maltophilia: a multicenter cohort study. Expert review of anti-infective therapy (2024)
Menyfah Q Alanazi, Waleed Abdelgawwad, Thamer A Almangour, Fatma Mostafa, Mona Almuheed
Impact of COVID-19 on the Health-Related Quality of Life of Patients during Infection and after Recovery in Saudi Arabia. International journal of environmental research and public health 20 (6) (2023)
Menyfah Q Alanazi, Waleed Abdelgawwad, Thamer A Almangour, Fatma Mostafa, Mona Almuheed
Impact of COVID-19 on the Health-Related Quality of Life of Patients during Infection and after Recovery in Saudi Arabia. International journal of environmental research and public health 20 (6) (2023)
Amany K Alkompoz, Samira M Hamed, Ahmed S Abu Zaid, Thamer A Almangour, Mohamed H M Al-Agamy, Khaled M A Aboshanab
Correlation of CRISPR/Cas and Antimicrobial Resistance in Klebsiella pneumoniae Clinical Isolates Recovered from Patients in Egypt Compared to Global Strains. Microorganisms 11 (8) (2023)
Menyfah Q Alanazi, Waleed Abdelgawwad, Thamer A Almangour, Fatma Mostafa, Mona Almuheed
Impact of COVID-19 on the Health-Related Quality of Life of Patients during Infection and after Recovery in Saudi Arabia. International journal of environmental research and public health 20 (6) (2023)
Thamer A Almangour, Leen Ghonem, Dareen Alassiri, Alanoud Aljurbua, Mohammed Al Musawa, Aminah Alharbi, Abdullah Almohaizeie, Sara Almuhisen, Jeelan Alghaith, Nader Damfu, Doaa Aljefri, Wafa Alfahad, Yaqoub Khormi, Menyfah Q Alanazi, Yazed Saleh Alsowaida
Ceftolozane-Tazobactam Versus Ceftazidime-Avibactam for the Treatment of Infections Caused by Multidrug-Resistant Pseudomonas aeruginosa: a Multicenter Cohort Study. Antimicrobial agents and chemotherapy (2023)
Aijaz Ahmad Reshi, Furqan Rustam, Wajdi Aljedaani, Shabana Shafi, Abdulaziz Alhossan, Ziyad Alrabiah, Ajaz Ahmad, Hessa Alsuwailem, Thamer A Almangour, Musaad A Alshammari, Ernesto Lee, Imran Ashraf
COVID-19 Vaccination-Related Sentiments Analysis: A Case Study Using Worldwide Twitter Dataset. Healthcare (Basel, Switzerland) 10 (3) (2022)
Menyfah Q Alanazi, Hajar AlQahtani, Thamer A Almangour, Fadilah Sfouq Aleanizy, Fulwah Yahya Alqahtani
Evaluation of the Clinical Outcome and Cost Analysis of Antibiotics in the Treatment of Acute Respiratory Tract Infections in the Emergency Department in Saudi Arabia. Antibiotics (Basel, Switzerland) 11 (11) (2022)
Yazed Saleh Alsowaida, Gregorio Benitez, Khalid Bin Saleh, Thamer A Almangour, Fadi Shehadeh, Eleftherios Mylonakis
Effectiveness and Safety of Ceftriaxone Compared to Standard of Care for Treatment of Bloodstream Infections Due to Methicillin-Susceptible Staphylococcus aureus : A Systematic Review and Meta-Analysis. Antibiotics (Basel, Switzerland) 11 (3) (2022)
Thamer A Almangour, Abdullah A Alhifany, Deanne E Tabb
Development and Validation of a Decision-Making Stratification Algorithm to Optimize the Use of Rapid Diagnostic Testing for Patients with Staphylococcus Bacteremia. The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale 2017 (2017)